This guideline covers diagnosing and managing non-small-cell and small-cell lung cancer. It aims to improve outcomes for patients by ensuring that the most effective tests and treatments are used, and that people have access to suitable palliative care and follow-up.
An International Women’s Day special Women in Respiratory is a community-led initiative here...
Join international Pulmonary Embolism (PE) expert Professor Stavros Konstantinides as he discusses...
Interstitial Lung Disease (ILD) is an umbrella term for lung disorders characterised by tissue...
Mesothelioma is a rare type of lung cancer, typically caused by Asbestos inhalation and commonly...
The GIRFT Tuberculosis (TB) report is a comprehensive, data-driven national review of TB services...